On May 10, 2023, PharmaCyte Biotech, Inc., closed the transaction. The company has raised a total of $35 million in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | -3.48% | -3.26% | -3.70% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.70% | 18.22M | |
+29.50% | 684B | |
+30.34% | 568B | |
-3.97% | 361B | |
+17.66% | 329B | |
+4.13% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.04% | 166B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc. announced that it has received $35 million in funding